Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ansuvimab (Ansuvimab-zyk) is a recombinant human monoclonal IgG1 antibody designed to combat Zaire ebolavirus by binding to its surface glycoprotein. This binding action inhibits the virus's entry into host cells, effectively exhibiting antiviral activity [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Ansuvimab (Ansuvimab-zyk) is a recombinant human monoclonal IgG1 antibody designed to combat Zaire ebolavirus by binding to its surface glycoprotein. This binding action inhibits the virus's entry into host cells, effectively exhibiting antiviral activity [1]. |
Molecular Weight | N/A |
CAS No. | 2375952-29-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ansuvimab 2375952-29-5 inhibitor inhibit